BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30887045)

  • 1. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
    Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
    Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
    Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
    Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.
    Wu IC; Liu WC; Chang TT
    J Biomed Sci; 2018 Jun; 25(1):51. PubMed ID: 29859540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
    Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
    Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
    Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
    Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
    Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
    Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
    J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology.
    Zhang R; Zhang F; Wang C; Wang S; Shiao YH; Guo Z
    J Exp Clin Cancer Res; 2010 Sep; 29(1):130. PubMed ID: 20849651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver.
    Wheelhouse NM; Lai PB; Wigmore SJ; Ross JA; Harrison DJ
    Br J Cancer; 2005 Apr; 92(7):1268-72. PubMed ID: 15785740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
    Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
    Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
    Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
    Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.
    Kong F; Kong D; Yang X; Yuan D; Zhang N; Hua X; You H; Zheng K; Tang R
    Cancer Med; 2020 Apr; 9(7):2462-2479. PubMed ID: 32017470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients.
    Teng CF; Huang HY; Li TC; Shyu WC; Wu HC; Lin CY; Su IJ; Jeng LB
    Sci Rep; 2018 Oct; 8(1):14816. PubMed ID: 30287845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA is a target of HBV integration.
    Giosa D; Lombardo D; Musolino C; Chines V; Raffa G; Casuscelli di Tocco F; D'Aliberti D; Caminiti G; Saitta C; Alibrandi A; Aiese Cigliano R; Romeo O; Navarra G; Raimondo G; Pollicino T
    Commun Biol; 2023 Jul; 6(1):684. PubMed ID: 37400627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutations in the D-loop region of mitochondrial DNA and the ROS level in the tissue of hepatocellular carcinoma].
    Huang XW; Zhao Q; Chen DZ; Zhang LS
    Yi Chuan; 2005 Jan; 27(1):14-20. PubMed ID: 15730952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.